Skip to content
10-Q

Quarterly Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-11-065145

← back to feed
Filed
Nov 15, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Nov 14, 2011 13.17M sh
Stockholders Equity Q2 2011 · Sep 30, 2011 $18.19M
Stockholders Equity Q2 2011 · Mar 31, 2011 $15M
Current Liabilities Q2 2011 · Sep 30, 2011 $1.21M
Current Liabilities Q2 2011 · Mar 31, 2011 $1.79M
Current Assets Q2 2011 · Sep 30, 2011 $6.34M
Current Assets Q2 2011 · Mar 31, 2011 $3.98M
Total Assets Q2 2011 · Sep 30, 2011 $20.3M
Total Assets Q2 2011 · Mar 31, 2011 $17.87M
Operating Cash Flow Q2 2011 · Sep 30, 2010 $583.96K
Sga Expense Q2 2011 · Sep 30, 2010 $343.73K
Sga Expense Q2 2011 · Sep 30, 2010 $430.81K
Net Income Q2 2011 · Sep 30, 2010 $346.27K
Net Income Q2 2011 · Sep 30, 2010 $1.28M
Operating Income Q2 2011 · Sep 30, 2010 $581.03K
Operating Income Q2 2011 · Sep 30, 2010 $1.87M
Gross Profit Q2 2011 · Sep 30, 2010 $981.53K
Gross Profit Q2 2011 · Sep 30, 2010 $2.4M
Cost Of Revenue Q2 2011 · Sep 30, 2010 $1.18M
Cost Of Revenue Q2 2011 · Sep 30, 2010 $2.98M